Details for New Drug Application (NDA): 206433
✉ Email this page to a colleague
NDA 206433 describes CLOZAPINE, which is a drug marketed by Barr Labs Inc, Mylan, Accord Hlthcare, Aurobindo Pharma, Dr Reddys Labs Sa, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Sun Pharm Inds Inc, and Zydus Pharms, and is included in twelve NDAs. It is available from ten suppliers. Additional details are available on the CLOZAPINE profile page.
The generic ingredient in CLOZAPINE is clozapine. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clozapine profile page.
The generic ingredient in CLOZAPINE is clozapine. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clozapine profile page.
Summary for 206433
| Tradename: | CLOZAPINE |
| Applicant: | Aurobindo Pharma |
| Ingredient: | clozapine |
| Patents: | 0 |
Suppliers and Packaging for NDA: 206433
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLOZAPINE | clozapine | TABLET;ORAL | 206433 | ANDA | Major Pharmaceuticals | 0904-7087 | 0904-7087-61 | 100 BLISTER PACK in 1 CARTON (0904-7087-61) / 1 TABLET in 1 BLISTER PACK |
| CLOZAPINE | clozapine | TABLET;ORAL | 206433 | ANDA | Major Pharmaceuticals | 0904-7088 | 0904-7088-61 | 100 BLISTER PACK in 1 CARTON (0904-7088-61) / 1 TABLET in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Nov 29, 2016 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Nov 29, 2016 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Nov 29, 2016 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
